Ratings by Canaccord (Arlinda Lee)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/7/2023 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Delcath Systems | DCTH | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2022 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2022 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Deciphera | DCPH | Downgrade | Hold (Buy) |
36.00 (25.59) |
-28.92% | Details | |
| 10/11/2021 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2021 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
16.95 (103.79) |
512.33% | Details | |
| 8/23/2021 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2021 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2021 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2021 | Delcath Systems | DCTH | New Coverage | Buy (N/A) |
17.65 (12.87) |
-27.08% | Details | |
| 12/14/2020 | Olema Pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
43.28 (11.85) |
-72.62% | Details | |
| 8/21/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2020 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2020 | Neoleukin Therapeutics | NLTX | New Coverage | Buy (N/A) |
7.96 (3.49) |
-56.16% | Details | |
| 3/3/2020 | Forty Seven Inc. | FTSV | Downgrade | Hold (Buy) |
58.00 (95.51) |
64.67% | Details | |
| 2/24/2020 | Black Diamond Therapeutics | BDTX | New Coverage | Buy (N/A) |
37.92 (1.90) |
-94.99% | Details | |
| 11/22/2019 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Forty Seven Inc. | FTSV | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2019 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2019 | BioNTech | BNTX | New Coverage | Buy (N/A) |
16.52 (90.07) |
445.22% | Details | |
| 10/28/2019 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2019 | Bicycle Therapeutics | BCYC | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2019 | Fibrocell Science | FCSC | Downgrade | Hold (Buy) |
2.92 (3.00) |
2.74% | Details | |
| 9/5/2019 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2019 | Forty Seven Inc. | FTSV | Maintain | Buy (Buy) |
|
Details | ||
| 8/14/2019 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2019 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2019 | CRISPR Therapeutics | CRSP | New Coverage | Buy (N/A) |
49.14 (50.63) |
3.03% | Details | |
| 5/21/2019 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
18.64 (4.05) |
-78.27% | Details | |
| 5/3/2019 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2019 | Harpoon Therapeutics | HARP | New Coverage | Buy (N/A) |
16.20 (23.01) |
42.04% | Details | |
| 2/12/2019 | Tyme Technologies | TYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Tyme Technologies | TYME | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2018 | Y-mAbs Therapeutics | YMAB | New Coverage | Buy (N/A) |
21.60 (8.61) |
-60.14% | Details |
